These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7319135)
1. Comparative pharmacokinetics of 400 mg bezafibrate after a single oral administration of a new slow-release preparation and the currently available commercial form. Ledermann H; Kaufmann B J Int Med Res; 1981; 9(6):516-20. PubMed ID: 7319135 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of bezafibrate in patients with impaired renal function. Anderson P; Norbeck HE Eur J Clin Pharmacol; 1981; 21(3):209-14. PubMed ID: 7318880 [TBL] [Abstract][Full Text] [Related]
4. Concentration of clofibric acid in blood after the administration of delayed-release form of etofibrate. Vazquez Lopez F; Armijo Castro F; Pire Solis I; Gutierrez Fuentes JA Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):31-5. PubMed ID: 3557726 [TBL] [Abstract][Full Text] [Related]
5. "In vitro" metabolism of bezafibrate by rat liver. Maffei FR; Carini M; Bertuletti R; Tofanetti O Pharmacol Res Commun; 1981 Feb; 13(2):121-32. PubMed ID: 7220572 [No Abstract] [Full Text] [Related]
6. Pharmacokinetics of bezafibrate after single and multiple doses in the presence of renal failure. Abshagen U; Kösters W; Kaufmann B; Lang PD Klin Wochenschr; 1980 Sep; 58(17):889-96. PubMed ID: 7442088 [No Abstract] [Full Text] [Related]
7. Comparative study of once and 3-times daily regimens of bezafibrate in patients with primary hyperlipoproteinaemia. Dick TB; Marples J; Ledermann HM; Whittington J Curr Med Res Opin; 1981; 7(8):489-502. PubMed ID: 7030635 [No Abstract] [Full Text] [Related]
8. [Pharmacokinetics of antilipemic agents. 4. Biotransformation of the antilipemic agent ciprofibrate (2-(4-(2,2-dichlorcyclopropyl)-phenoxy)-2-methylpropionic acid)]. Oelschläger H; Rothley D; Schmidt W Arch Pharm (Weinheim); 1988 Jun; 321(6):367-70. PubMed ID: 3178437 [No Abstract] [Full Text] [Related]
9. Relative bioavailability of etofibrate. A comparison of an acute and a new sustained release formulation. Johnson KI; Hoppe HJ; Schatton W Arzneimittelforschung; 1984; 34(12):1785-7. PubMed ID: 6543315 [TBL] [Abstract][Full Text] [Related]
10. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia]. Bolzano K; Krempler F; Schellenberg B; Schlierf G Acta Med Austriaca; 1979; 6(3):90-4. PubMed ID: 547652 [TBL] [Abstract][Full Text] [Related]
11. [Bezafibrate and delayed action etofibrate in hyperlipidemia]. Lang PD; Vollmar J Dtsch Med Wochenschr; 1983 Feb; 108(8):302-5. PubMed ID: 6825604 [No Abstract] [Full Text] [Related]
12. The short- and long-term effects of bezafibrate in the rat. Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842 [TBL] [Abstract][Full Text] [Related]
13. The influence of renal insufficiency and haemodialysis on the kinetics of ciprofibrate. Ferry N; Bernard N; Pozet N; Gardes E; Cuisinaud G; Labeeuw M; Zech PY; Sassard J Br J Clin Pharmacol; 1989 Dec; 28(6):675-81. PubMed ID: 2611089 [TBL] [Abstract][Full Text] [Related]
14. [Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia]. Lageder H Wien Klin Wochenschr; 1980 Feb; 92(3):95-101. PubMed ID: 6985560 [TBL] [Abstract][Full Text] [Related]
17. Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients. Grützmacher P; Scheuermann E; Lang W Proc Eur Dial Transplant Assoc; 1981; 18():169-75. PubMed ID: 7036147 [TBL] [Abstract][Full Text] [Related]
18. Bezafibrate: lack of effect on creatinine excretion and muscular proteins. Mertz DP; Lang PD; Vollmar J Res Exp Med (Berl); 1982; 180(1):95-8. PubMed ID: 7079594 [TBL] [Abstract][Full Text] [Related]
19. Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs. Garrett ER; Altmayer P J Pharm Sci; 1985 Mar; 74(3):295-9. PubMed ID: 4009437 [TBL] [Abstract][Full Text] [Related]
20. Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats. Walli AK; Seidel D Res Exp Med (Berl); 1981; 179(2):153-61. PubMed ID: 7280363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]